Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

ADVERTISEMENT


almanac button

submit article ideas here

ADVERTISEMENT
PharmTech Poll
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
pharmtech's list of regulatory databases
Foss

Content Uniformity Made Easy
MidwescoŽ Filter Resources, Inc

Global Leader
Metrics

Custom Engineered Potent Products Facility

ADVERTISEMENT
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways

Last updated on Wed May 22 23:07:15 EDT 2013

Drug Layering onto Fine Particles
September 25, 2012
Binders in Tablet Manufacturing
July 7, 2010
Advertiser Gallery
Click here